PLCG2 and COVID-19: Another 2022 study found no elevated anti-S1 IgA levels in a subject carrying a mutation in the PLCG2 gene after a booster dose of BNT vaccine, suggesting a role of PLCG2 after COVID-19 vaccination (64).